Anzeige
Mehr »
Montag, 20.04.2026 - Börsentäglich über 12.000 News
China - das Pentagon - und dieses Unternehmen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von GlobeNewswire (USA)

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10:06Niu Technologies to Report First Quarter 2026 Financial Results on May 18, 2026
10:06Octopus Apollo VCT plc: Re-Opening of Offer for Subscription to Further Applications
09:42Jyske Realkredit A/S: Data on debtor composition
09:36Jyske Realkredit A/S: Preliminary data on early redemptions (prepayments)
09:06Ringkjøbing Landbobank A/S: Share buyback programme - week 16
08:36Jyske Bank: Share repurchase programme: Transactions of week 16 2026
08:36Diversified Energy Company: Diversified Energy TR-1
08:06ICG Enterprise Trust Plc: Transaction in Own Shares
08:06OSB GROUP PLC - Transaction in Own Shares
08:06Bang & Olufsen A/S: Major Shareholder Announcement
08:06Equinor ASA: Buy-back of shares to share programmes for employees
07:36TGS ASA: TGS Webcast Details for Q1 2026 Presentation
07:12AS Infortar: Aktsiaselts Infortar own share acquisition transactions
07:06AS Infortar: Aktsiaselts Infortar to continue buy-back of up to 250,000 own shares
07:06A subsidiary of EfTEN Real Estate Fund AS sold an office building at Menulio 11 in Vilnius
07:06Trifork Group AG: Trifork Announces New Board Members to Advance Product-Led Growth and AI Strategy
07:06RUBIS: Composition of the Supervisory Board
02:06ASCENTAGE PHARMA GROUP INTERNATIONAL: Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
01:48Sutro Biopharma, Inc.: Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
01:06Monopar Therapeutics Inc.: Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026
SoTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
SoRevolution Medicines, Inc.: Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting
SaPliant Therapeutics, Inc.: Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
Saargenx SE: argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
SaGrupo Aeroportuario del Pacífico, S.A.B. de C.V.: Grupo Aeroportuario del Pacifico Announces Filing of 2025 Annual Report and Form 20-F